SK

Sangeetha Kalarikal Chandrashekaran

Active Director Designated Partner DIN 00381452
DIN 00381452 First appointment Jul 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sangeetha Kalarikal Chandrashekaran

Data last updated:

Sangeetha Kalarikal Chandrashekaran is a Designated Partner at Gateway2health Llp (since 2018). The company operates in Healthcare.

DIN 00381452
Primary Designation Designated Partner
Industry Healthcare
First Appointment 07 Jul 2018
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Jul 20182017Active

Board colleagues of Sangeetha Kalarikal Chandrashekaran

NameDINCompanyDesignation
Christopher Noronha07710217Gateway2health LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Gateway2health Llp
Premium access

Shareholding and investment profile for Sangeetha Kalarikal Chandrashekaran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangeetha Kalarikal Chandrashekaran

Sangeetha Kalarikal Chandrashekaran currently holds 1 directorship: Gateway2health Llp (Designated Partner, since 07 Jul 2018).

Sangeetha Kalarikal Chandrashekaran was first appointed on 07 Jul 2018 as Designated Partner at Gateway2health Llp.

The current boards of Sangeetha Kalarikal Chandrashekaran's companies include Christopher Noronha (Gateway2health Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available